Correction to: The Development and Validation of a Decision Aid to Enhance Shared Decision-Making for the Management of Actinic Keratosis
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNonmelanoma Skin Cancer Studies
This is a correction to: Geoffrey Brent, Caroline Beardmore, Kate Mayers, Alberto Barea, Venura Samarasinghe, Vanessa Pinder, Julia Soo, Victoria Akhras, Zainab Jiyad, The Development and Validation of a Decision Aid to Enhance Shared Decision-Making for the Management of Actinic Keratosis, Skin Health and Disease, Volume 4, Issue 3, June 2024, https://doi.org/10.1002/ski2.388
In Figure 1, the cell in row ‘What are the risks and side effects’ and column ‘No treatment’, which reads: “There is a 0.075% (75 in a thousand chance)” should read instead: “There is a less than 1% chance”.
The emendation has been made in the article.